| HNSCC | Head and neck squamous cell carcinoma |
| ESCRT | Endosomal sorting complex required for transport |
| TCGA | The Cancer Genome Atlas |
| VPS25 | Vacuolar Protein Sorting 25 Homolog |
| HR | Hazard ratio |
| NOM | Normal oral mucosa |
| OS | Overall survival |
| DFS | Disease-free survival |
| TMAs | Tissue microarrays |
| IHC | Immunohistochemistry |
| TME | Tumor microenvironment |
| scRNA-seq | Single-cell RNA sequencing |
| CNV | Copy number variation |
| UMAP | Uniform manifold approximation and projection |
| pEMT | Partial epithelial–mesenchymal transition |
| ST | Spatial transcriptomics |
| DEG | Differentially expressed gene |
| GSEA | Gene set enrichment analysis |
| NES | Normalized enrichment score |
| FDR | False discovery rate |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| GOBP | Gene ontology biological process |
| RSS | Regulon specificity score |
| TILs | Tumor-infiltrating lymphocytes |
| TIMs | Tumor-infiltrating myeloid cells |
| TAMs | Tumor-associated macrophages |
| MDSCs | Myeloid-derived suppressor cells |
| Tregs | Regulatory T cells |
| PVR | Poliovirus receptor |
| TIDE | Tumor immune dysfunction and exclusion |
| ICB | immune checkpoint blockade |
| Im | Immunotherapy |
| IC | Immunotherapy combined therapy |
| R | Response |
| NR | Non-response |
| CR | Complete response |
| PR | Partial response |
| SD | Stable disease |
| PD | Progressive disease |